• BREAKING NEWS ABC shows live and on-demand -- Download the WATCH ABC app!

Safety of cholesterol drug reviewed

August 22, 2008 12:10:54 PM PDT
The FDA is reviewing the safety of the cholesterol drug Vytorin following a clinical study showing the drug might increase the risk of cancer.A congressional committee is giving the drug's makers two weeks to produce the data included in the study.

The companies say they will cooperate fully with the request.

In the meantime, the FDA says the apparent cancer risk is low enough that patients should not stop taking Vytorin or other cholesterol-lowering drugs.


- Get more L.A. breaking news, weather, traffic and sports
- Have a news tip? Send your tips, video, or pictures